Specials Laboratory to supply clinical trials service to UK hospitals

Published: 29-Mar-2010

New service aims to meet the product manufacturing needs of NHS-based clinical trials

Hospitals across the UK will be able to take advantage of a new service aimed at meeting the product manufacturing needs of NHS-based clinical trials.

The Specials Laboratory, based in Northumberland, is to specialise in the supply of non-sterile products for use in small-scale clinical studies direct to hospitals after the specialist firm was licensed for the manufacture of investigational medicinal products (IMPs).

The new IMP service will assist clinical trial pharmacists and technicians, university medical schools and research doctors.

Operating from three MHRA-approved facilities, the company complies with current Good Manufacturing Practice (cGMP) and provides in-house Quality Person (QP) release, which will ensure products delivered to hospitals will be made to the highest possible quality standards.

‘Our quality-led manufacturing heritage allows us to produce virtually any non-sterile dosage form,’ said Robert Sludden, Quality and Technical Services Manager at The Specials Laboratory.

‘The company is also able to offer customers an experienced technical team that includes several pharmacists, senior pharmacy technicians and QPs – many with an extensive NHS background.’

With more hospitals opting to subcontract their IMP manufacturing needs, The Specials Laboratory is looking to build relationships with relevant NHS departments by offering to be their outsourced manufacturing partner supplying products for smaller clinical trials.

‘Hospital departments will be able to source a wide range of products from The Specials Laboratory for their IMP manufacturing requirements, including oral liquids, capsules, sachets, ointments, creams, ear and nasal drops, enema solutions, suppositories and pessaries,' added Sludden.

Set-up over a decade ago, The Specials Laboratory employs around 130 people and is a leading UK manufacturer of unlicensed medicines, which are bespoke for individual patients and supplied to community and hospital pharmacists and doctors.

  • Companies:
  • The Specials Laboratory Ltd
See more

You may also like

Manufacturing

PCCA buys the specials business and Arjun Products from UDG Healthcare for £23.5m

Read more
Deal includes The Specials Laboratory and Craig & Hayward in Northumberland, UK

Trending Articles

  1. Serialisation and data connectivity: Part I The new wrinkle in your supply chain
  2. Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
  3. SGS’s Shanghai Health Science laboratory completes US FDA inspection with zero 483 observations SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection by the US Food and Drug Administration (FDA) of its Shanghai Health Science Laboratory
  4. Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche Acquisition extends Lonza’s US Biologics footprint with a significant presence on the West Coast, complementing its existing global manufacturing network
  5. SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

You may also like

Manufacturing

PCCA buys the specials business and Arjun Products from UDG Healthcare for £23.5m

Deal includes The Specials Laboratory and Craig & Hayward in Northumberland, UK
Manufacturing

AI-driven manufacturing: revolutionising chemical additive optimisation for industrial processes

The integration of artificial intelligence (AI) and machine learning (ML) into manufacturing processes represents a significant leap forward for the industry, reports Josh Galloway, AI Consultant at Schneider Electric
Ingredients

Clariant introduces new high-performing excipients at the CPHI Milan 2024 trade show

Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI trade show in Milan
Packaging

Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Manufacturing

The IMA Group at CPHI Milan: welcoming you to Booth 18A1

Discover the all-in-one supplier for the pharmaceutical, personal care, homecare and toiletry Industries
Manufacturing

Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma

Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
Marketing

Gerresheimer at CPHI 2024: innovative solutions and expert presentations

Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, will be presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions at this year's CPHI
Subscribe now